0001567619-21-022297.txt : 20211217
0001567619-21-022297.hdr.sgml : 20211217
20211217190334
ACCESSION NUMBER: 0001567619-21-022297
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211210
FILED AS OF DATE: 20211217
DATE AS OF CHANGE: 20211217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES
CENTRAL INDEX KEY: 0001221590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 211503182
MAIL ADDRESS:
STREET 1: 925 PAGE MILL ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2021-12-10
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001221590
BIENAIME JEAN JACQUES
C/O BIOMARIN PHARMACEUTICAL INC.
770 LINDARO ST.
SAN RAFAEL
CA
94901
1
1
0
0
Chief Executive Officer
Common Stock
2021-12-10
5
G
0
700
0
D
303689
D
Common Stock
2021-12-15
4
M
0
6000
37.46
A
309689
D
Common Stock
2021-12-15
4
S
0
6000
82.71
D
303689
D
Common Stock
2021-12-16
4
M
0
6000
37.46
A
309689
D
Common Stock
2021-12-16
4
S
0
6000
84.68
D
303689
D
Common Stock
247533
I
Shares held by Jean-Jacques Bienaime Family Trust
Stock Option (Right to buy Common Stock)
37.46
2021-12-15
4
M
0
6000
0
D
2012-11-08
2022-05-07
Common Stock
6000
131000
D
Stock Option (Right to buy Common Stock)
37.46
2021-12-16
4
M
0
6000
0
D
2012-11-08
2022-05-07
Common Stock
6000
125000
D
On December 10, 2021 the reporting person gifted 700 shares to an educational institution.
Trade made pursuant to a 10b5-1 plan executed on October 13, 2021.
Reflects the number of options outstanding after the transactions from this specific stock option grant.
/s/ Eric Fleekop, Attorney-in-Fact
2021-12-17